• 2'3'-cGAMP (sodium salt): Applied Protocols in STING Pathway

  2026-06-26

  2'3'-cGAMP (sodium salt) empowers researchers to dissect the cGAS-STING pathway with unmatched affinity and water solubility, enabling reproducible activation of type I interferon responses. Discover advanced workflows, strategic troubleshooting, and protocol upgrades for immunology and radiotherapy resistance studies.

• 2'3'-cGAMP (sodium salt): Precision Tool for STING Pathway R

  2026-06-26

  2'3'-cGAMP (sodium salt) offers unmatched specificity and potency for dissecting the cGAS-STING signaling pathway and innate immune responses. This article details protocol innovations, troubleshooting, and translational advantages for immunology and cancer research using APExBIO’s gold-standard reagent.

• RapaLink-1: Redefining mTOR Inhibition for Dormancy & Oncolo

  2026-06-25

  Explore how RapaLink-1, a third-generation mTOR inhibitor, advances both embryonic dormancy models and cancer research through its unprecedented bivalent mechanism. This article provides mechanistic insights, protocol guidance, and translational perspectives for researchers aiming to unlock novel workflows in developmental biology and oncology.

• Neuromedin S (rat): Technical Use and Protocol Parameters

  2026-06-25

  Neuromedin S (rat) provides a chemically defined, endogenous peptide agonist for controlled activation of neuromedin U receptor signaling in rat-based GPCR/G protein research. It is suitable for in vitro and ex vivo workflows that require precise ligand identity and solubility, but it is not intended for diagnostic, therapeutic, or in vivo applications. Proper handling and storage are critical to maintain peptide integrity and assay reproducibility.

• Gastrin I: Precision Pathways in Gastric Acid Secretion Rese

  2026-06-24

  Human Gastrin I peptide enables targeted dissection of gastric acid secretion pathways in advanced in vitro models, from hiPSC-derived intestinal organoids to classic parietal cell assays. APExBIO’s high-purity reagent delivers reproducible performance, with troubleshooting strategies and protocol enhancements that streamline GI pathway research and translational applications.

• Chloroquine and Everolimus Drive Apoptosis and Lipid Shifts

  2026-06-23

  This study demonstrates that combining chloroquine and everolimus robustly induces apoptosis and alters lipid distribution in melanoma cells. These mechanistic insights highlight the synergy between autophagy inhibition and mTOR pathway modulation, offering practical directions for cancer therapy development and advanced cell viability assay design.

• Promethazine HCl: Advanced Workflows in Immunology Research

  2026-06-23

  Promethazine HCl empowers researchers to dissect histaminergic and GPCR-mediated signaling, with unique strengths in immune metabolism and host-pathogen studies. Its reproducible solubility, high purity, and validated action on macrophage ROS and autophagy set it apart for inflammation and neuroscience workflows.

• ARCA EGFP mRNA (5-moUTP): Polyadenylated mRNA for Reliable F

  2026-06-22

  ARCA EGFP mRNA (5-moUTP) is a polyadenylated mRNA tool for direct fluorescence-based transfection control in mammalian cells. Its design ensures high translational efficiency, low immunogenicity, and robust protein expression, validated by peer-reviewed and manufacturer data.

• Dimethyloxalylglycine (DMOG): Technical Use and Protocol Gui

  2026-06-22

  Dimethyloxalylglycine (DMOG) provides a controlled means to stabilize hypoxia-inducible factors in cell and animal models, supporting mechanistic studies in hypoxia signaling and inflammation. It should not be used in diagnostic or therapeutic settings, and its utility depends on strict adherence to solubility and workflow recommendations.

• Single-Dose Indometacin Sodium for Acute Postoperative Pain:

  2026-06-21

  This article reviews the Cochrane systematic analysis of single-dose oral indometacin sodium for acute postoperative pain, highlighting methodological rigor and clinical relevance. The findings clarify the efficacy, safety, and protocol nuances for sodium 2-(1-(4-chlorobenzoyl)-5-methoxy-2-methyl-1H-indol-3-yl)acetate in pain management and inform translational anti-inflammatory research.

• Foxp1 Suppresses Notch-Mediated EndMT to Reduce Valve Calcif

  2026-06-20

  This study demonstrates that endothelial Foxp1 overexpression suppresses Notch pathway activation, thereby inhibiting endothelial-to-mesenchymal transition (EndMT) and reducing valvular calcification in chronic kidney disease (CKD) models. These findings elucidate a mechanistic link between PTH-driven EndMT and Foxp1-mediated protection, highlighting new regulatory nodes for intervention in CKD-associated cardiovascular complications.

• Indazole/Indole-Based Glucagon Receptor Antagonists: Synthes

  2026-06-19

  A novel series of indazole- and indole-based glucagon receptor antagonists has been synthesized, offering new candidates for type 2 diabetes therapy. The study advances synthetic methodology and provides potent, orally active compounds targeting hepatic glucose production.

• Estradiol in Cellular Stress Defense: Mechanisms and Assay I

  2026-06-19

  Explore how estradiol, the primary female sex hormone, orchestrates advanced cellular stress defenses via estrogen receptor signaling. This article unveils new mechanistic insights—beyond organ protection—highlighting estradiol's role in cellular homeostasis and research assay design.

• 2-Deoxy-D-glucose: Unraveling Immunometabolic Targets in Dis

  2026-06-18

  Explore how 2-Deoxy-D-glucose (2-DG) uniquely modulates immune cell metabolism and apoptosis, with new insights for cancer and autoimmune research. This article delves into advanced mechanistic findings, protocol parameters, and translational considerations.

• Cannabis Terpenes Relieve Neuropathic Pain via A2A Receptors

  2026-06-18

  Schwarz et al. demonstrate that select terpenes from Cannabis sativa produce potent antinociceptive effects in mouse models of chronic neuropathic pain by activating adenosine A2A receptors, rather than cannabinoid pathways. This study clarifies the mechanistic distinction between terpenes and cannabinoids, highlighting a non-rewarding, receptor-specific strategy for pain management.

16253 records 1/1084 page Next 12345 下5页 Last page